Cadila Healthcare submits press release

24 Jul 2019

Cadila Healthcare has informed about submission of a copy of press release dated July 24, 2019 titled ‘Zydus has launched Ramelteon Tablets in the US upon receiving final approval from the USFDA’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Related Cadila Healthcare Ltd. Links:

Cadila Healthcare Share Price

271.95 2.85 (1.06%) Jan 24, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 447.70
Lupin 740.10
Dr. Reddys Lab 3028.05
Piramal Enterprises 1676.55
Cadila Healthcare 271.95
View more..
Sensex vs Cadila Healthcare
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463